DE60235642D1 - Charakterisierung von molekülen - Google Patents

Charakterisierung von molekülen

Info

Publication number
DE60235642D1
DE60235642D1 DE60235642T DE60235642T DE60235642D1 DE 60235642 D1 DE60235642 D1 DE 60235642D1 DE 60235642 T DE60235642 T DE 60235642T DE 60235642 T DE60235642 T DE 60235642T DE 60235642 D1 DE60235642 D1 DE 60235642D1
Authority
DE
Germany
Prior art keywords
species
signatures
interactions
characterize
phase partitioning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60235642T
Other languages
English (en)
Inventor
Arnon Chait
Boris Y Zaslavsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Analiza Inc
Original Assignee
Analiza Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Analiza Inc filed Critical Analiza Inc
Application granted granted Critical
Publication of DE60235642D1 publication Critical patent/DE60235642D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/5375Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831Protein or peptide standard or control [e.g., hemoglobin, etc.]
DE60235642T 2001-11-12 2002-11-12 Charakterisierung von molekülen Expired - Lifetime DE60235642D1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33689501P 2001-11-12 2001-11-12
US35247302P 2002-01-28 2002-01-28
US36166102P 2002-03-04 2002-03-04
US41275402P 2002-09-23 2002-09-23
PCT/US2002/036519 WO2003042694A2 (en) 2001-11-12 2002-11-12 Characterization of molecules

Publications (1)

Publication Number Publication Date
DE60235642D1 true DE60235642D1 (de) 2010-04-22

Family

ID=27502555

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60235642T Expired - Lifetime DE60235642D1 (de) 2001-11-12 2002-11-12 Charakterisierung von molekülen

Country Status (8)

Country Link
US (3) US7968350B2 (de)
EP (1) EP1444515B1 (de)
JP (1) JP2005509856A (de)
AT (1) ATE460665T1 (de)
CA (1) CA2466663A1 (de)
DE (1) DE60235642D1 (de)
ES (1) ES2342713T3 (de)
WO (1) WO2003042694A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003016883A1 (en) * 2001-08-16 2003-02-27 Analiza, Inc. A method of measuring solubility
US7968350B2 (en) 2001-11-12 2011-06-28 Analiza, Inc. Characterization of molecules
US7024955B2 (en) 2003-03-01 2006-04-11 Symyx Technologies, Inc. Methods and systems for dissolution testing
US8099242B2 (en) 2003-06-12 2012-01-17 Analiza, Inc. Systems and methods for characterization of molecules
US20060155186A1 (en) * 2005-01-12 2006-07-13 James Timothy W Bone health assessment using spatial-frequency analysis
WO2007062255A2 (en) * 2005-11-27 2007-05-31 Osteotronix, Limited Assessment of structures such as bone using spatial-frequency analysis
EP1977254B1 (de) 2005-12-19 2012-02-08 Analiza, Inc. Verfahren unter beteiligung von datenmustern, wie etwa spektralen biomarkern
EP2031528A4 (de) * 2006-05-26 2009-06-17 Univ Kyoto Schätzung der proteinverbindungswechselwirkung und rationaler entwurf einer verbindungsbibliothek auf der basis chemischer genomischer informationen
US20110105855A1 (en) * 2009-10-30 2011-05-05 Trustees Of Tufts College Early detection of cognition impairment in elderly population
WO2014025961A1 (en) 2012-08-10 2014-02-13 Analiza, Inc. Methods and devices for analyzing species to determine diseases
US9678076B2 (en) * 2014-06-24 2017-06-13 Analiza, Inc. Methods and devices for determining a disease state
US10957421B2 (en) 2014-12-03 2021-03-23 Syracuse University System and method for inter-species DNA mixture interpretation
US11150181B2 (en) * 2017-12-05 2021-10-19 Jp3 Measurement, Llc Method for computing and comparing digital signatures of hydrocarbons
CA3168953A1 (en) 2020-02-28 2021-09-02 Analiza, Inc. Systems and methods for determining viruses such as coronaviruses
US11535902B2 (en) 2021-03-17 2022-12-27 Analiza, Inc. RNA separation and related techniques for determining viruses such as coronaviruses
WO2023076036A1 (en) 2021-10-28 2023-05-04 Analiza, Inc. Partitioning systems and methods for determining multiple types of cancers

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008204A (en) * 1988-02-02 1991-04-16 Exxon Chemical Patents Inc. Method for determining the compositional distribution of a crystalline copolymer
US5340474A (en) * 1988-03-24 1994-08-23 Terrapin Technologies, Inc. Panels of analyte-binding ligands
US5241072A (en) * 1990-05-25 1993-08-31 Genzyne Corporation Oligosaccharide oxazolines, oligosaccharide conjugates and methods of preparation thereof
US5311131A (en) * 1992-05-15 1994-05-10 Board Of Regents Of The University Of Washington Magnetic resonance imaging using pattern recognition
AU1837495A (en) * 1994-10-13 1996-05-06 Horus Therapeutics, Inc. Computer assisted methods for diagnosing diseases
US5837203A (en) * 1996-04-09 1998-11-17 Sievers Instruments, Inc. Device to alternately supply a fluid to an analyzer
US5734024A (en) * 1996-04-19 1998-03-31 Boris Y. Zaslavsky Method for determining the biological activity of recombinant human growth hormone
US5948750A (en) * 1996-10-30 1999-09-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
WO1998046756A1 (en) * 1997-04-16 1998-10-22 Millennium Biotherapeutics Secreted protein ssp-1 compositions and therapeutic and diagnostic uses therefor
WO2000010674A1 (en) * 1997-08-19 2000-03-02 Arnon Chait Method for evaluation of the ratio of amounts of biomolecules or their sub-populations in a mixture
JP2001514375A (ja) * 1997-08-22 2001-09-11 パーデュー・リサーチ・ファウンデーション 多重膜擬似親和力を利用する薬物の発見支援
DE19903576C2 (de) * 1999-01-29 2001-02-22 Bodenseewerk Perkin Elmer Co Quantitative Bestimmung von Analyten in einem heterogenen System
US6451849B1 (en) * 1999-03-30 2002-09-17 Hormos Nutraceutical Oy Ltd. Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol
CA2382436C (en) * 1999-08-30 2011-05-17 Illumina, Inc. Methods for improving signal detection from an array
EP1250587A1 (de) 2000-01-28 2002-10-23 Pion, Inc. MESSUNG VON LÖSLICHKEITS-pH-PROFILEN
US9709559B2 (en) * 2000-06-21 2017-07-18 Bioarray Solutions, Ltd. Multianalyte molecular analysis using application-specific random particle arrays
US20020102577A1 (en) * 2000-07-31 2002-08-01 Raillard Sun Ai Nucleotide incorporating enzymes
GB0031566D0 (en) * 2000-12-22 2001-02-07 Mets Ometrix Methods for spectral analysis and their applications
WO2003016883A1 (en) 2001-08-16 2003-02-27 Analiza, Inc. A method of measuring solubility
US7968350B2 (en) 2001-11-12 2011-06-28 Analiza, Inc. Characterization of molecules
US20040236603A1 (en) * 2003-05-22 2004-11-25 Biospect, Inc. System of analyzing complex mixtures of biological and other fluids to identify biological state information
US8099242B2 (en) * 2003-06-12 2012-01-17 Analiza, Inc. Systems and methods for characterization of molecules
US20060269964A1 (en) * 2003-06-12 2006-11-30 Arnon Chait Systems and methods for characterization of molecules
WO2005008247A2 (en) 2003-07-11 2005-01-27 Science & Technology Corporation @ Unm. Detection of endometrial pathology
US7391016B2 (en) 2005-05-12 2008-06-24 Analiza, Inc. Method for quantitative analysis of mixtures of compounds
US20070048786A1 (en) 2005-09-01 2007-03-01 Arnon Chait Systems and methods for fractionation of protein mixtures
EP1977254B1 (de) 2005-12-19 2012-02-08 Analiza, Inc. Verfahren unter beteiligung von datenmustern, wie etwa spektralen biomarkern

Also Published As

Publication number Publication date
EP1444515A2 (de) 2004-08-11
US20110218738A1 (en) 2011-09-08
WO2003042694A2 (en) 2003-05-22
US20120245856A1 (en) 2012-09-27
CA2466663A1 (en) 2003-05-22
US20030162224A1 (en) 2003-08-28
US7968350B2 (en) 2011-06-28
ATE460665T1 (de) 2010-03-15
WO2003042694A3 (en) 2004-02-26
ES2342713T3 (es) 2010-07-13
WO2003042694B1 (en) 2004-04-08
JP2005509856A (ja) 2005-04-14
US8211714B2 (en) 2012-07-03
EP1444515B1 (de) 2010-03-10

Similar Documents

Publication Publication Date Title
ATE460665T1 (de) Charakterisierung von molekülen
DE60138810D1 (de) Vorrichtung mit integrierter mikromatrize
IS7611A (is) Örfylki og aðferð til þess að framkvæma blöndunarhvörf fyrir fjölda sýna á einu örfylki
ATE330038T1 (de) Nukleinsäure-biosensor
MX2021011543A (es) Sistemas de fluidos de punto de cuidado y usos de los mismos.
DE60325180D1 (de) Mikrovorrichtungen zur untersuchung von biologischen systemen
DK1766400T3 (da) Fremgangsmåde til at udföre fuldblodsanalyser
DE50210457D1 (de) Vorrichtung zur referenzierung von fluoreszenzsignalen
ATE531529T1 (de) Wertdokument, herstellung und prüfung von wertdokumenten
ATE430621T1 (de) Biologische vorrichtung
WO2004011144A3 (en) Transparent polymer support for electrophoresis and electrochromatography and related methods
ATE377193T1 (de) Analyse von massenspektraldaten in den ruhigen gebieten
NO20021787L (no) Fremgangsmåte for bestemmelse av stoffer ved hjelp av evaneschensfeltfremgangsmåten
ITRN20030024A1 (it) Dispositivo per il prelievo di campioni biologici e/o chimici.
DE60143531D1 (de) Vorrichtung, verfahren und verwendung zur behandlung von proben
ATE259964T1 (de) Kompetitives assay-verfahren
ATE365324T1 (de) Nachweis durch serrs in mikrofluidischer umgebung
WO2003011768A3 (en) Microfluidic device for molecular analysis
SE0004334D0 (sv) Electron spectroscopy
DE50211356D1 (de) Hybridverfahren zur herstellung von trägern für die analytbestimmung
DE60217079D1 (de) Nachweis und quantifizierung von cripto-1
Benotti et al. HPLC/TOF-MS: an alternative to LC/MS/MS for sensitive and selective determination of polar organic contaminants in the aquatic environment
ES2173048B1 (es) Instrumento y metodo para el analisis, identificacion y cuantificacion de gases o liquidos.
DE50208262D1 (de) Verfahren zur bestimmung von flüchtigen substanzen in lösung
DE60224663D1 (de) Verwendung einer miniaturvorrichtung zur trennung und isolierung biologischer objekte und trennungsverfahren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition